Lifeward Expands Distribution Partnership with SportsMed Ltd. to Add Coverage for United Arab Emirates and Entire Gulf Cooperation Council Region
Lifeward Ltd. (Nasdaq: LFWD), a medical technology company, has expanded its distribution partnership with SportsMed Products Ltd. to include the United Arab Emirates and the entire Gulf Cooperation Council (GCC) region. The expansion will be managed through SportsMed's Dubai-based entity, SportsMed Performance Trading LLC.
SportsMed Products has been the exclusive AlterG dealer in the UK and Ireland since 2015, with a track record of selling over 300 AlterG devices. The company has already established a demo zone in Dubai featuring the latest AlterG NEO+ system, demonstrating their commitment to the GCC market expansion.
Lifeward Ltd. (Nasdaq: LFWD), un'azienda nel settore delle tecnologie mediche, ha ampliato la sua partnership di distribuzione con SportsMed Products Ltd. includendo gli Emirati Arabi Uniti e l'intera regione del Consiglio di Cooperazione del Golfo (GCC). L'espansione sarà gestita tramite la società di SportsMed con sede a Dubai, SportsMed Performance Trading LLC.
SportsMed Products è stato il rivenditore esclusivo di AlterG nel Regno Unito e in Irlanda dal 2015, con un record di oltre 300 dispositivi AlterG venduti. L'azienda ha già allestito una zona demo a Dubai con l'ultimo sistema AlterG NEO+, dimostrando così il proprio impegno nell'espansione del mercato GCC.
Lifeward Ltd. (Nasdaq: LFWD), una empresa de tecnología médica, ha ampliado su asociación de distribución con SportsMed Products Ltd. para incluir a los Emiratos Árabes Unidos y toda la región del Consejo de Cooperación del Golfo (GCC). La expansión será gestionada a través de la entidad de SportsMed con sede en Dubái, SportsMed Performance Trading LLC.
SportsMed Products ha sido el distribuidor exclusivo de AlterG en el Reino Unido e Irlanda desde 2015, con un historial de venta de más de 300 dispositivos AlterG. La empresa ya ha establecido una zona de demostración en Dubái con el último sistema AlterG NEO+, demostrando su compromiso con la expansión del mercado GCC.
Lifeward Ltd. (나스닥: LFWD)는 의료 기술 회사로서 SportsMed Products Ltd.와의 유통 파트너십을 아랍에미리트 및 걸프협력회의(GCC) 전역으로 확대하였습니다. 이번 확장은 SportsMed의 두바이 법인인 SportsMed Performance Trading LLC를 통해 관리됩니다.
SportsMed Products는 2015년부터 영국과 아일랜드에서 AlterG 독점 딜러로, 300대 이상의 AlterG 장비를 판매한 실적을 보유하고 있습니다. 또한 최신 AlterG NEO+ 시스템을 갖춘 두바이 데모존을 이미 구축하여 GCC 시장 확장에 대한 의지를 보여주고 있습니다.
Lifeward Ltd. (Nasdaq : LFWD), une entreprise de technologie médicale, a étendu son partenariat de distribution avec SportsMed Products Ltd. pour inclure les Émirats arabes unis et l'ensemble de la région du Conseil de coopération du Golfe (CCG). Cette expansion sera gérée par l'entité de SportsMed basée à Dubaï, SportsMed Performance Trading LLC.
SportsMed Products est le distributeur exclusif d'AlterG au Royaume-Uni et en Irlande depuis 2015, avec un historique de vente de plus de 300 dispositifs AlterG. L'entreprise a déjà mis en place une zone de démonstration à Dubaï présentant le dernier système AlterG NEO+, témoignant de son engagement envers l'expansion du marché du CCG.
Lifeward Ltd. (Nasdaq: LFWD), ein Medizintechnikunternehmen, hat seine Vertriebspartnerschaft mit SportsMed Products Ltd. erweitert, um die Vereinigten Arabischen Emirate und die gesamte Golf-Kooperationsrat (GCC)-Region einzuschließen. Die Erweiterung wird über die in Dubai ansässige Einheit von SportsMed, SportsMed Performance Trading LLC, verwaltet.
SportsMed Products ist seit 2015 der exklusive AlterG-Händler im Vereinigten Königreich und Irland und hat über 300 AlterG-Geräte verkauft. Das Unternehmen hat bereits eine Demo-Zone in Dubai mit dem neuesten AlterG NEO+ System eingerichtet, was ihr Engagement für die Expansion im GCC-Markt unterstreicht.
- Expansion into 6 new GCC countries through established partner
- Partner has proven track record with over 300 AlterG devices sold
- Demo zone already operational in Dubai with latest NEO+ system
- Building on successful long-term partnership since 2015
- None.
Insights
Lifeward's expansion into UAE/GCC via established partner SportsMed strengthens global distribution network and creates revenue growth opportunity.
Lifeward's distribution expansion for its AlterG product lines into the United Arab Emirates and entire Gulf Cooperation Council region represents a strategic geographic growth initiative with notable potential. This move leverages their existing successful partnership with SportsMed Products Ltd., which has already demonstrated strong performance in the UK and Ireland markets since 2015, with over 300 AlterG devices sold in those regions.
The expansion is particularly significant because it builds upon a proven relationship rather than establishing an untested channel. SportsMed's experience with the AlterG product line means minimal learning curve and faster market penetration. They've already established a demo zone in Dubai showcasing the latest AlterG NEO+ system, indicating preparedness for immediate market entry.
The GCC region, comprising Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and the UAE, represents a valuable market opportunity with high healthcare spending per capita and investments in medical technology. These wealthy nations are actively diversifying their healthcare infrastructure, creating fertile ground for advanced rehabilitation technology like the AlterG systems, which are typically used for precise body weight-supported physical therapy and rehabilitation.
This geographic expansion aligns with Lifeward's strategy as a "global leader in innovative medical technology" for people with physical limitations. By expanding distribution into regions with substantial healthcare investment and modernization initiatives, Lifeward positions itself to capture new revenue streams while advancing its mission of transforming lives through accessibility to specialized mobility technology.
Expansion adds additional AlterG dealer coverage to 6 countries throughout the Gulf Cooperation Council region
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Aug. 04, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced the expansion of its relationship with SportsMed Products Ltd. (“SMP Ltd.”) to include distribution of the AlterG product lines within the United Arab Emirates (“UAE”) as well as throughout the entire Gulf Cooperation Council (“GCC”) through their Dubai-based company SportsMed Performance Trading LLC.
“Expanding our distribution capabilities into the UAE and the broader GCC is a critical step in driving the success and global reach of the AlterG product lines,” said Mark Grant, CEO of Lifeward Ltd. “We have great confidence in our long-standing partnership with SMP Ltd., whose strong history of performance with the AlterG and commitment to excellence make them the ideal partner to support this next phase of growth.”
SMP Ltd. has been the exclusive AlterG dealer within the United Kingdom and Republic of Ireland since 2015, with the company originating from AlterG employees from 2010. They have already sold over 300 AlterG devices, and have a strong focus on providing bespoke training, servicing and maintenance to each customer. Operating as SportsMed Performance Trading LLC in the GCC, SportsMed has already launched a new demo zone in Dubai where customers can experience the latest AlterG NEO+ system.
To learn more about SportsMed Performance Trading LLC, please visit www.sportsmed.ae
To learn more about AlterG international distribution coverage, please visit https://alterg.com/international-distributors
About Lifeward
Lifeward designs, develops, and commercializes life-changing solutions that span the continuum of care in physical rehabilitation and recovery, delivering proven functional and health benefits in clinical settings as well as in the home and community. Our mission at Lifeward is to relentlessly drive innovation to change the lives of individuals with physical limitations or disabilities. We are committed to delivering groundbreaking solutions that empower individuals to do what they love. The Lifeward portfolio features innovative products including the ReWalk Exoskeleton, the AlterG Anti-Gravity System, the ReStore Exo-Suit, and the MyoCycle FES System. Founded in 2001, Lifeward has operations in the United States, Israel, and Germany.
Lifeward®, ReWalk®, ReStore®, and Alter G® are registered trademarks of Lifeward Ltd. and/or its affiliates.
Forward-Looking Statements
In addition to historical information, this press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, and Section 21E of the U.S. Securities Exchange Act of 1934. Such forward-looking statements may include projections regarding the Company's future performance and other statements that are not statements of historical fact and, in some cases, may be identified by words like "anticipate," "assume," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "future," "will," "should," "would," "seek" and similar terms or phrases. The forward-looking statements contained in this press release are based on management's current expectations, which are subject to uncertainty, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. Important factors that could cause the Company’s actual results to differ materially from those indicated in the forward-looking statements include, among others: the acceptance of the ReWalk 7 Personal Exoskeleton by healthcare professionals and patients; uncertainties associated with future clinical trials and the clinical development process, the product development process and FDA regulatory submission review and approval process; the Company's ability to have sufficient funds to meet certain future capital requirements, which could impair the Company's efforts to develop and commercialize existing and new products; the Company's ability to maintain and grow its reputation and the market acceptance of its products; the Company's ability to achieve reimbursement from third-party payors, including CMS, for its products; the Company's limited operating history and its ability to leverage its sales, marketing and training infrastructure; the Company's expectations as to its clinical research program and clinical results; the Company's expectations regarding future growth, including its ability to increase sales in its existing geographic markets and expand to new markets; the Company's ability to obtain certain components of its products from third-party suppliers and its continued access to its product manufacturers; the Company’s ability to navigate any difficulties associated with moving production of its AlterG Anti-Gravity Systems to a contract manufacturer; the Company's ability to improve its products and develop new products; the Company's compliance with medical device reporting regulations to report adverse events involving the Company's products, which could result in voluntary corrective actions or enforcement actions such as mandatory recalls, and the potential impact of such adverse events on the Company's ability to market and sell its products; the Company's ability to gain and maintain regulatory approvals; the Company's ability to maintain adequate protection of its intellectual property and to avoid violation of the intellectual property rights of others; the risk of a cybersecurity attack or breach of the Company's IT systems significantly disrupting its business operations; the Company's ability to use effectively the proceeds of its offerings of securities; and other factors discussed under the heading "Risk Factors" in the Company’s annual report on Form 10-K, as amended, for the year ended December 31, 2024 filed with the SEC and other documents subsequently filed with or furnished to the SEC. Any forward-looking statement made in this press release speaks only as of the date hereof. Factors or events that could cause the Company’s actual results to differ from the statements contained herein may emerge from time to time, and it is not possible for the Company to predict all of them. Except as required by law, the Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future developments or otherwise.
Lifeward Media Relations:
Kathleen O’Donnell
Vice President, Marketing & New Business Development
Lifeward Ltd.
E: media@golifeward.com
Lifeward Investor Contact:
Almog Adar
Vice President of Finance
Lifeward Ltd.
E: ir@golifeward.com
FAQ
What regions did Lifeward (LFWD) expand its distribution to in August 2025?
Who is Lifeward's distribution partner for AlterG products in the GCC region?
How many AlterG devices has SportsMed sold in their existing markets?
Where can customers experience the AlterG NEO+ system in the UAE?
How long has SportsMed been Lifeward's AlterG dealer in the UK and Ireland?
